GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
批准号:
2837466
负责人:
WILLIAM C RASCHKE
金额:
$32.31万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 2002-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The leukocyte common antigen CD45 has received considerable attention
recently as evidence accumulates for its role in signal transduction
during immune responses. CD45 has the interesting properties of (a)
expression restricted to nucleated hematopoietic cells, (b) multiple
isoforms which differ in the extracellular domain, (c) strictly
regulated expression of the different isoforms in the various
hematopoietic lineages, (d) a large cytoplasmic domain with protein
tyrosine phosphatase (PTPase) activity and (e) associations with
complexes at the cell surface involved in signal transduction. The CD45
molecule appears to be an important participant in the function of the
cells expressing it. Studies with cell lines have indicated CD45 is
essential for optimal signaling via cell surface receptors on T and B
lymphocytes and possibly, by extrapolation, other hematopoietic lineage
cells. The PTPase activity of the cytoplasmic domain appears critical
for the signaling function. The model that is emerging is CD45 functions
to control the state of phosphorylation of src family protein tyrosine
kinases, members of which have been shown to play roles in signaling
through the T cell receptor and B cell antigen receptor. The principal
studies to date that have led to our present concept of CD45 function
have used artificial in vitro systems. A major issue hindering progress
in answering further questions concerning CD45 and its role is the poor
ability to express CD45 from its cDNA. Even when successful, other
promoters not having the distinctive expression characteristics of CD45
have had to be used. The experiments proposed address the function of
CD45 structural components in vivo by introducing mutations into the
complete CD45 gene. The roles of the extracellular domain, the
cytoplasmic domain and critical functional sites will be evaluated in
this manner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
siRNA Modulation of the Immune Response
-
批准号:8459220
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2013
-
负责人:WILLIAM C RASCHKE
-
依托单位:
siRNA Modulation of the Immune Response
-
批准号:8601289
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2013
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Novel Immune Modulator/ Adjuvant for HIV Vaccines
-
批准号:7555097
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2008
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Novel Immune Modulator/ Adjuvant for HIV Vaccines
-
批准号:7651191
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2008
-
负责人:WILLIAM C RASCHKE
-
依托单位:
Hemophilia A: Intrathymic Delivery for Tolerance and Longterm Expression of FVIII
-
批准号:7324891
-
项目类别:
-
资助金额:$14.99万
-
财政年份:2007
-
负责人:WILLIAM C RASCHKE
-
依托单位:
Non-Integrating FIV Vectors for HIV Vaccines
-
批准号:7270086
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2006
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:8239890
-
项目类别:
-
资助金额:$5.47万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:7910804
-
项目类别:
-
资助金额:$90.58万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:8268486
-
项目类别:
-
资助金额:$69.95万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
FIV Vectors for the Treatment of Hemophilia A
-
批准号:8077953
-
项目类别:
-
资助金额:$100.94万
-
财政年份:2005
-
负责人:WILLIAM C RASCHKE
-
依托单位:
COMPLEMENTARY ADENOVIRAL VECTORS FOR TREATMENT OF CANCER
-
批准号:6335431
-
项目类别:
-
资助金额:$26.26万
-
财政年份:2000
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6174295
-
项目类别:
-
资助金额:$33.58万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:2903083
-
项目类别:
-
资助金额:$33.58万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Mini-Ad Vector for Treatment of Factor VIII Deficiency
-
批准号:6527227
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6522316
-
项目类别:
-
资助金额:$34.72万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6377459
-
项目类别:
-
资助金额:$34.72万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
A Mini-Ad Vector for Treatment of Factor VIII Deficiency
-
批准号:6404702
-
项目类别:
-
资助金额:$37.5万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
MOLECULAR ANALYSIS RESOURCE FOR PRIMARY HUMAN CANCERS
-
批准号:6637095
-
项目类别:
-
资助金额:$34.72万
-
财政年份:1999
-
负责人:WILLIAM C RASCHKE
-
依托单位:
GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
-
批准号:6475709
-
项目类别:
-
资助金额:$35.65万
-
财政年份:1997
-
负责人:WILLIAM C RASCHKE
-
依托单位:
GENETIC ANALYSIS OF REGULATION AND FUNCTION OF CD45
-
批准号:6328742
-
项目类别:
-
资助金额:$35.74万
-
财政年份:1997
-
负责人:WILLIAM C RASCHKE
-
依托单位:
海外基金